We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$710M
AUM Growth
-$45.7M
Cap. Flow
-$39.7M
Cap. Flow %
-5.59%
Top 10 Hldgs %
9.53%
Holding
2,469
New
584
Increased
596
Reduced
458
Closed
638

Sector Composition

Rank Sector Weight
1 Technology 11.11%
2 Energy 9.76%
3 Consumer Discretionary 8.51%
4 Industrials 8.43%
5 Healthcare 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1451
Enterprise Products Partners
EPD
$81.7B
$40K 0.01%
1,000
PPLI
1452
People Inc
PPLI
$3.1B
$40K 0.01%
+3,357
New +$40.6K
SUI icon
1453
Sun Communities
SUI
$14.7B
$40K 0.01%
800
THS
1454
DELISTED
Treehouse Foods
THS
$40K 0.01%
500
WD icon
1455
Walker & Dunlop
WD
$1.53B
$40K 0.01%
3,000
DRE
1456
DELISTED
Duke Realty Corp.
DRE
$40K 0.01%
2,300
EGOV
1457
DELISTED
NIC Inc
EGOV
$40K 0.01%
2,300
+700
+44% +$12.3K
ORIT
1458
DELISTED
Oritani Financial Corp. New
ORIT
$40K 0.01%
2,810
+510
+22% +$7.58K
NILE
1459
DELISTED
Blue Nile, Inc.
NILE
$40K 0.01%
1,400
+560
+67% +$15.6K
LOCK
1460
DELISTED
LifeLock, Inc.
LOCK
$40K 0.01%
2,800
SGNT
1461
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$40K 0.01%
1,300
-4,600
-78% -$125K
SFXE
1462
CALL
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$40K 0.01%
8,000
CBST
1463
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$40K 0.01%
+600
New +$39.4K
IOSP icon
1464
Innospec
IOSP
$2.28B
$39K 0.01%
1,100
+130
+13% +$5.28K
JBSS icon
1465
John B. Sanfilippo & Son
JBSS
$972M
$39K 0.01%
1,200
-200
-14% -$5.8K
NBIX icon
1466
Neurocrine Biosciences
NBIX
$16.6B
$39K 0.01%
2,500
-5,000
-67% -$74.7K
NVEC icon
1467
NVE Corp
NVEC
$609M
$39K 0.01%
600
ONTO icon
1468
Onto Innovation
ONTO
$15.3B
$39K 0.01%
+2,600
New +$43.6K
SQM icon
1469
Sociedad Química y Minera de Chile
SQM
$20.6B
$39K 0.01%
1,541
CTG
1470
DELISTED
Computer Task Group, Inc.
CTG
$39K 0.01%
+3,500
New +$48K
CNCE
1471
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$39K 0.01%
+3,100
New +$30.1K
BSTC
1472
DELISTED
BioSpecifics Technologies Corp.
BSTC
$39K 0.01%
+1,100
New +$32.3K
AEIS icon
1473
Advanced Energy
AEIS
$13B
$38K 0.01%
2,000
-300
-13% -$5.52K
BC icon
1474
Brunswick
BC
$5.28B
$38K 0.01%
+900
New +$38.1K
CHCO icon
1475
City Holding Co
CHCO
$2.04B
$38K 0.01%
+900
New +$38.6K

Similar funds

Prelude Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Prelude Capital Management held 2,469 positions worth $710M, down 6% from $756M the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Prelude Capital Management withdrew a net $39.7M in Q3 2014, closing 638 positions and reducing 458 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $5.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.1% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in CONCUR TECHNOLOGIES INC worth $6.4M.

  • Prelude Capital Management's largest Q3 2014 buy was CONCUR TECHNOLOGIES INC: 50,447 shares worth $6.4M.
  • Prelude Capital Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, an estimated $6.42M increase.
  • Prelude Capital Management's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $4.48M.
  • Prelude Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.64M.
  • Prelude Capital Management's ten largest holdings make up 9.5% of its $710M portfolio in Q3 2014.
  • Prelude Capital Management opened 584 new positions and closed 638 in Q3 2014.
  • Prelude Capital Management's portfolio value fell 6% quarter-over-quarter to $710M.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.